These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32483248)
1. Preparation of high drug-loading celastrol nanosuspensions and their anti-breast cancer activities in vitro and in vivo. Huang T; Wang Y; Shen Y; Ao H; Guo Y; Han M; Wang X Sci Rep; 2020 Jun; 10(1):8851. PubMed ID: 32483248 [TBL] [Abstract][Full Text] [Related]
2. Preparation of hydroxy genkwanin nanosuspensions and their enhanced antitumor efficacy against breast cancer. Ao H; Li Y; Li H; Wang Y; Han M; Guo Y; Shi R; Yue F; Wang X Drug Deliv; 2020 Dec; 27(1):816-824. PubMed ID: 32489130 [TBL] [Abstract][Full Text] [Related]
3. Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy. Li H; Liu B; Ao H; Fu J; Wang Y; Feng Y; Guo Y; Wang X J Nanobiotechnology; 2020 Jan; 18(1):4. PubMed ID: 31907045 [TBL] [Abstract][Full Text] [Related]
4. Genkwanin nanosuspensions: a novel and potential antitumor drug in breast carcinoma therapy. Li Y; Hong J; Li H; Qi X; Guo Y; Han M; Wang X Drug Deliv; 2017 Nov; 24(1):1491-1500. PubMed ID: 28961040 [TBL] [Abstract][Full Text] [Related]
5. Celastrol-loaded polymeric mixed micelles shows improved antitumor efficacy in 4 T1 bearing xenograft mouse model through spatial targeting. Gautam S; Singh N; Marwaha D; Rai N; Sharma M; Tiwari P; Singh S; Kumar Bakshi A; Kumar A; Agarwal N; Prakash Shukla R; Ranjan Mishra P Int J Pharm; 2024 Jun; 659():124234. PubMed ID: 38763310 [TBL] [Abstract][Full Text] [Related]
6. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice. Li H; Li Y; Ao H; Bi D; Han M; Guo Y; Wang X Drug Deliv; 2018 Nov; 25(1):880-887. PubMed ID: 29608108 [TBL] [Abstract][Full Text] [Related]
7. Annonaceous acetogenins (ACGs) nanosuspensions based on a self-assembly stabilizer and the significantly improved anti-tumor efficacy. Hong J; Li Y; Xiao Y; Li Y; Guo Y; Kuang H; Wang X Colloids Surf B Biointerfaces; 2016 Sep; 145():319-327. PubMed ID: 27209384 [TBL] [Abstract][Full Text] [Related]
8. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107 [TBL] [Abstract][Full Text] [Related]
9. Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect. Chen Y; Liu J; Yang X; Zhao X; Xu H J Pharm Pharmacol; 2005 Feb; 57(2):259-64. PubMed ID: 15720792 [TBL] [Abstract][Full Text] [Related]
10. Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy. Hong J; Li Y; Li Y; Xiao Y; Kuang H; Wang X Int J Nanomedicine; 2016; 11():3239-53. PubMed ID: 27486323 [TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and evaluation of the antitumor effect of kaempferol nanosuspensions. He W; Zhang J; Ju J; Wu Y; Zhang Y; Zhan L; Li C; Wang Y Drug Deliv Transl Res; 2023 Nov; 13(11):2885-2902. PubMed ID: 37149557 [TBL] [Abstract][Full Text] [Related]
12. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity. Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability. Thadkala K; Nanam PK; Rambabu B; Sailu C; Aukunuru J Int J Pharm Investig; 2014 Jul; 4(3):131-7. PubMed ID: 25126526 [TBL] [Abstract][Full Text] [Related]
14. Folic acid-modified celastrol nanoparticles: synthesis, characterization, anticancer activity in 2D and 3D breast cancer models. Law S; Leung AW; Xu C Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):542-559. PubMed ID: 32054336 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions. Li H; Li M; Fu J; Ao H; Wang W; Wang X Drug Deliv; 2021 Dec; 28(1):1226-1236. PubMed ID: 34142631 [TBL] [Abstract][Full Text] [Related]
16. Particle size tailoring of ursolic acid nanosuspensions for improved anticancer activity by controlled antisolvent precipitation. Wang Y; Song J; Chow SF; Chow AH; Zheng Y Int J Pharm; 2015 Oct; 494(1):479-89. PubMed ID: 26302857 [TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and assessment of the antiglioma effects of liposomal celastrol. Huang Y; Zhou D; Hang T; Wu Z; Liu J; Xu Q; Xie X; Zuo J; Wang Z; Zhou Y Anticancer Drugs; 2012 Jun; 23(5):515-24. PubMed ID: 22343423 [TBL] [Abstract][Full Text] [Related]
18. Folate-modified Annonaceous acetogenins nanosuspensions and their improved antitumor efficacy. Hong J; Sun Z; Li Y; Guo Y; Liao Y; Liu M; Wang X Int J Nanomedicine; 2017; 12():5053-5067. PubMed ID: 28765708 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment. Sun S; Guan Q; Shang E; Xiao H; Yu X; Shi L; Zhao C; Guo Y; Lv S; Li Y Pak J Pharm Sci; 2020 Jan; 33(1):109-119. PubMed ID: 32122838 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy. Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]